Review





Similar Products

95
Developmental Studies Hybridoma Bank markers
Markers, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/markers/product/Developmental Studies Hybridoma Bank
Average 95 stars, based on 1 article reviews
markers - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

94
Bioss china bs 2007r
China Bs 2007r, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/china bs 2007r/product/Bioss
Average 94 stars, based on 1 article reviews
china bs 2007r - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

94
Bioss pcna antibody
Pcna Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcna antibody/product/Bioss
Average 94 stars, based on 1 article reviews
pcna antibody - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

94
Miltenyi Biotec lymphatic endothelial cell lec specific marker
Lymphatic Endothelial Cell Lec Specific Marker, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphatic endothelial cell lec specific marker/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
lymphatic endothelial cell lec specific marker - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

99
Miltenyi Biotec cd11b surface marker
A. BCLAF1 expression levels across cancer types from the TCGA dataset. B. BCLAF1 expression in LAML patient samples (n = 173) and normal hematopoietic tissues (n = 70), shown as log 2 (TPM + 1). C. Growth competition experiments showing the percentage of GFP-positive cells between day 2 and day 15 following infection with LentiCRISPRv2GFP constructs expressing individual sgRNAs targeting the indicated genes. Data represent mean ± SEM of three biological replicates (*p < 0.05, ***p < 0.001; two-way ANOVA). D. Immunoblot analysis of BCLAF1 protein levels in shCONTROL and shBCLAF1 cells treated or not with DOX for 96 hours. β-tubulin was used as a loading control. E. Flow cytometry analysis showing the percentage of <t>CD11b-positive</t> cells in shCONTROL and shBCLAF1 cells treated with DOX for 96h. Data represent mean ± SEM of three biological replicates (*p < 0.05, ***p < 0.001; unpaired t-test). F. Dot plot of GO terms enriched among genes up-regulated in BCLAF1-low versus BCLAF1-high patient samples from the BEAT-AML cohort. GeneRatio indicates the proportion of significantly upregulated genes associated with each GO term. Dot size reflects the number of genes per term; color denotes adjusted p-value. G. Kaplan-Meier curve shows survival of mice transplanted with MLL-AF9 expressing Bclaf1 f/f (black) or Vav-Cre:Bclaf1 f/f (blue) HSPCs. Briefly, HSPCs from CD45.2 + Bclaf1 f/f or Vav-Cre:Bclaf1 f/f mice were transduced with retrovirus co-expressing MLL-AF9 and GFP then transplanted with 300,000 CD45.1 + recipient bone marrow cells into lethally-irradiated CD45.1 + recipient mice (schematic in Figure S1G). Leukemic burden was assessed by percentage of GFP + cells in peripheral blood. Mice were euthanized once peripheral blood had ≥ 80% leukemia. Inset shows median survival. Bclaf1 f/f , n=23; Vav-Cre:Bclaf1 f/f , n=24. H. Primary Bclaf1 f/f AMLs isolated from mice in G were transduced with retroviral vector expressing Thy1.1 (empty control, black) or Thy1.1 and Cre recombinase (blue) then expanded as mixed co-cultures with nontransduced cells. Bar graphs show percentage of transduced cells (Thy1.1 + ) at day 7 of mixed co-culture relative to day 0 transduction efficiency. Data repesent mean ± SD of 3 independent experiments (**p ≤ 0.01; unpaired t-test). I. Primary Bclaf1 f/f AMLs isolated from mice in G were transduced with retroviral vectors as in D. Thy1.1 + cells were enriched by flow cytometric sorting and cultured in complete methocult media. Total colony forming units were quantitated at day 7 of culture. Data repesent mean ± SD of 3 independent experiments (*p ≤ 0.05; unpaired t-test).
Cd11b Surface Marker, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd11b surface marker/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
cd11b surface marker - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

98
Thermo Fisher neuronal markers
A. BCLAF1 expression levels across cancer types from the TCGA dataset. B. BCLAF1 expression in LAML patient samples (n = 173) and normal hematopoietic tissues (n = 70), shown as log 2 (TPM + 1). C. Growth competition experiments showing the percentage of GFP-positive cells between day 2 and day 15 following infection with LentiCRISPRv2GFP constructs expressing individual sgRNAs targeting the indicated genes. Data represent mean ± SEM of three biological replicates (*p < 0.05, ***p < 0.001; two-way ANOVA). D. Immunoblot analysis of BCLAF1 protein levels in shCONTROL and shBCLAF1 cells treated or not with DOX for 96 hours. β-tubulin was used as a loading control. E. Flow cytometry analysis showing the percentage of <t>CD11b-positive</t> cells in shCONTROL and shBCLAF1 cells treated with DOX for 96h. Data represent mean ± SEM of three biological replicates (*p < 0.05, ***p < 0.001; unpaired t-test). F. Dot plot of GO terms enriched among genes up-regulated in BCLAF1-low versus BCLAF1-high patient samples from the BEAT-AML cohort. GeneRatio indicates the proportion of significantly upregulated genes associated with each GO term. Dot size reflects the number of genes per term; color denotes adjusted p-value. G. Kaplan-Meier curve shows survival of mice transplanted with MLL-AF9 expressing Bclaf1 f/f (black) or Vav-Cre:Bclaf1 f/f (blue) HSPCs. Briefly, HSPCs from CD45.2 + Bclaf1 f/f or Vav-Cre:Bclaf1 f/f mice were transduced with retrovirus co-expressing MLL-AF9 and GFP then transplanted with 300,000 CD45.1 + recipient bone marrow cells into lethally-irradiated CD45.1 + recipient mice (schematic in Figure S1G). Leukemic burden was assessed by percentage of GFP + cells in peripheral blood. Mice were euthanized once peripheral blood had ≥ 80% leukemia. Inset shows median survival. Bclaf1 f/f , n=23; Vav-Cre:Bclaf1 f/f , n=24. H. Primary Bclaf1 f/f AMLs isolated from mice in G were transduced with retroviral vector expressing Thy1.1 (empty control, black) or Thy1.1 and Cre recombinase (blue) then expanded as mixed co-cultures with nontransduced cells. Bar graphs show percentage of transduced cells (Thy1.1 + ) at day 7 of mixed co-culture relative to day 0 transduction efficiency. Data repesent mean ± SD of 3 independent experiments (**p ≤ 0.01; unpaired t-test). I. Primary Bclaf1 f/f AMLs isolated from mice in G were transduced with retroviral vectors as in D. Thy1.1 + cells were enriched by flow cytometric sorting and cultured in complete methocult media. Total colony forming units were quantitated at day 7 of culture. Data repesent mean ± SD of 3 independent experiments (*p ≤ 0.05; unpaired t-test).
Neuronal Markers, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neuronal markers/product/Thermo Fisher
Average 98 stars, based on 1 article reviews
neuronal markers - by Bioz Stars, 2026-02
98/100 stars
  Buy from Supplier

95
Bioss endothelial cell marker
Dynamic changes in angiogenesis induced by OTM. ( A ) Representative CD31 immunofluorescence staining images. CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of CD31 + area in PDL. ( C ) Representative CD31/vascular <t>endothelial</t> growth factor (VEGF) double immunofluorescence staining images. CD31/VEGF staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( D ) Quantitative analysis of VEGF + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; *** p < 0.001; Welch’s ANOVA with Games–Howell post hoc test. PDL: periodontal ligament, AB: alveolar bone.
Endothelial Cell Marker, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endothelial cell marker/product/Bioss
Average 95 stars, based on 1 article reviews
endothelial cell marker - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

91
Bioss senescence marker
Presence and distribution of senescent cells during OTM. ( A ) Representative p21 and p16 immunofluorescence staining images with DAPI. ( B ) Quantitative analysis of p21 + area in PDL. ( C ) Quantitative analysis of p16 + area in PDL. ( D , E ) Distribution of <t>senescence</t> marker–positive areas in the 60 g and 180 g groups. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). * p < 0.05; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test. PDL: periodontal ligament, AB: alveolar bone.
Senescence Marker, supplied by Bioss, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/senescence marker/product/Bioss
Average 91 stars, based on 1 article reviews
senescence marker - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

93
Biotium anti mouse cd4 antibody
Presence and distribution of senescent cells during OTM. ( A ) Representative p21 and p16 immunofluorescence staining images with DAPI. ( B ) Quantitative analysis of p21 + area in PDL. ( C ) Quantitative analysis of p16 + area in PDL. ( D , E ) Distribution of <t>senescence</t> marker–positive areas in the 60 g and 180 g groups. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). * p < 0.05; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test. PDL: periodontal ligament, AB: alveolar bone.
Anti Mouse Cd4 Antibody, supplied by Biotium, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd4 antibody/product/Biotium
Average 93 stars, based on 1 article reviews
anti mouse cd4 antibody - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

97
Miltenyi Biotec astrocyte surface marker 184 glutamate aspartate transporter glast
Presence and distribution of senescent cells during OTM. ( A ) Representative p21 and p16 immunofluorescence staining images with DAPI. ( B ) Quantitative analysis of p21 + area in PDL. ( C ) Quantitative analysis of p16 + area in PDL. ( D , E ) Distribution of <t>senescence</t> marker–positive areas in the 60 g and 180 g groups. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). * p < 0.05; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test. PDL: periodontal ligament, AB: alveolar bone.
Astrocyte Surface Marker 184 Glutamate Aspartate Transporter Glast, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/astrocyte surface marker 184 glutamate aspartate transporter glast/product/Miltenyi Biotec
Average 97 stars, based on 1 article reviews
astrocyte surface marker 184 glutamate aspartate transporter glast - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier

Image Search Results


A. BCLAF1 expression levels across cancer types from the TCGA dataset. B. BCLAF1 expression in LAML patient samples (n = 173) and normal hematopoietic tissues (n = 70), shown as log 2 (TPM + 1). C. Growth competition experiments showing the percentage of GFP-positive cells between day 2 and day 15 following infection with LentiCRISPRv2GFP constructs expressing individual sgRNAs targeting the indicated genes. Data represent mean ± SEM of three biological replicates (*p < 0.05, ***p < 0.001; two-way ANOVA). D. Immunoblot analysis of BCLAF1 protein levels in shCONTROL and shBCLAF1 cells treated or not with DOX for 96 hours. β-tubulin was used as a loading control. E. Flow cytometry analysis showing the percentage of CD11b-positive cells in shCONTROL and shBCLAF1 cells treated with DOX for 96h. Data represent mean ± SEM of three biological replicates (*p < 0.05, ***p < 0.001; unpaired t-test). F. Dot plot of GO terms enriched among genes up-regulated in BCLAF1-low versus BCLAF1-high patient samples from the BEAT-AML cohort. GeneRatio indicates the proportion of significantly upregulated genes associated with each GO term. Dot size reflects the number of genes per term; color denotes adjusted p-value. G. Kaplan-Meier curve shows survival of mice transplanted with MLL-AF9 expressing Bclaf1 f/f (black) or Vav-Cre:Bclaf1 f/f (blue) HSPCs. Briefly, HSPCs from CD45.2 + Bclaf1 f/f or Vav-Cre:Bclaf1 f/f mice were transduced with retrovirus co-expressing MLL-AF9 and GFP then transplanted with 300,000 CD45.1 + recipient bone marrow cells into lethally-irradiated CD45.1 + recipient mice (schematic in Figure S1G). Leukemic burden was assessed by percentage of GFP + cells in peripheral blood. Mice were euthanized once peripheral blood had ≥ 80% leukemia. Inset shows median survival. Bclaf1 f/f , n=23; Vav-Cre:Bclaf1 f/f , n=24. H. Primary Bclaf1 f/f AMLs isolated from mice in G were transduced with retroviral vector expressing Thy1.1 (empty control, black) or Thy1.1 and Cre recombinase (blue) then expanded as mixed co-cultures with nontransduced cells. Bar graphs show percentage of transduced cells (Thy1.1 + ) at day 7 of mixed co-culture relative to day 0 transduction efficiency. Data repesent mean ± SD of 3 independent experiments (**p ≤ 0.01; unpaired t-test). I. Primary Bclaf1 f/f AMLs isolated from mice in G were transduced with retroviral vectors as in D. Thy1.1 + cells were enriched by flow cytometric sorting and cultured in complete methocult media. Total colony forming units were quantitated at day 7 of culture. Data repesent mean ± SD of 3 independent experiments (*p ≤ 0.05; unpaired t-test).

Journal: bioRxiv

Article Title: BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia

doi: 10.64898/2026.01.19.700325

Figure Lengend Snippet: A. BCLAF1 expression levels across cancer types from the TCGA dataset. B. BCLAF1 expression in LAML patient samples (n = 173) and normal hematopoietic tissues (n = 70), shown as log 2 (TPM + 1). C. Growth competition experiments showing the percentage of GFP-positive cells between day 2 and day 15 following infection with LentiCRISPRv2GFP constructs expressing individual sgRNAs targeting the indicated genes. Data represent mean ± SEM of three biological replicates (*p < 0.05, ***p < 0.001; two-way ANOVA). D. Immunoblot analysis of BCLAF1 protein levels in shCONTROL and shBCLAF1 cells treated or not with DOX for 96 hours. β-tubulin was used as a loading control. E. Flow cytometry analysis showing the percentage of CD11b-positive cells in shCONTROL and shBCLAF1 cells treated with DOX for 96h. Data represent mean ± SEM of three biological replicates (*p < 0.05, ***p < 0.001; unpaired t-test). F. Dot plot of GO terms enriched among genes up-regulated in BCLAF1-low versus BCLAF1-high patient samples from the BEAT-AML cohort. GeneRatio indicates the proportion of significantly upregulated genes associated with each GO term. Dot size reflects the number of genes per term; color denotes adjusted p-value. G. Kaplan-Meier curve shows survival of mice transplanted with MLL-AF9 expressing Bclaf1 f/f (black) or Vav-Cre:Bclaf1 f/f (blue) HSPCs. Briefly, HSPCs from CD45.2 + Bclaf1 f/f or Vav-Cre:Bclaf1 f/f mice were transduced with retrovirus co-expressing MLL-AF9 and GFP then transplanted with 300,000 CD45.1 + recipient bone marrow cells into lethally-irradiated CD45.1 + recipient mice (schematic in Figure S1G). Leukemic burden was assessed by percentage of GFP + cells in peripheral blood. Mice were euthanized once peripheral blood had ≥ 80% leukemia. Inset shows median survival. Bclaf1 f/f , n=23; Vav-Cre:Bclaf1 f/f , n=24. H. Primary Bclaf1 f/f AMLs isolated from mice in G were transduced with retroviral vector expressing Thy1.1 (empty control, black) or Thy1.1 and Cre recombinase (blue) then expanded as mixed co-cultures with nontransduced cells. Bar graphs show percentage of transduced cells (Thy1.1 + ) at day 7 of mixed co-culture relative to day 0 transduction efficiency. Data repesent mean ± SD of 3 independent experiments (**p ≤ 0.01; unpaired t-test). I. Primary Bclaf1 f/f AMLs isolated from mice in G were transduced with retroviral vectors as in D. Thy1.1 + cells were enriched by flow cytometric sorting and cultured in complete methocult media. Total colony forming units were quantitated at day 7 of culture. Data repesent mean ± SD of 3 independent experiments (*p ≤ 0.05; unpaired t-test).

Article Snippet: These samples were stained using CD11b surface marker and Annexin V kit (Annexin V-FITC Kit, Miltenyi Biotec).

Techniques: Expressing, Infection, Construct, Western Blot, Control, Flow Cytometry, Transduction, Irradiation, Isolation, Retroviral, Plasmid Preparation, Co-Culture Assay, Cell Culture

A. Immunoblot analysis of BCLAF1 and ATF4 protein levels in shCONTROL and shBCLAF1 cells treated with DOX for 96 hours. β-tubulin was used as a loading control. B. Immunoblot analysis of BCLAF1 and ATF4 protein levels in MLL-AF9-expressing AML cells of indicated genotypes. GAPDH was used as a loading control. C. Immunoblot analysis of BCLAF1 and ATF4 protein levels in shCONTROL and shATF4 cells treated with DOX for 96 hours. β-tubulin was used as a loading control. D. Cell proliferation assay (CellTiter-Blue-based) in shCONTROL and shATF4 cells treated or not with DOX for 96 hours, followed by 96 additional hours in culture. Data represent mean ± SEM of three biological replicates (*p < 0.01; paired t-test). E. Flow cytometry analysis showing the percentage of CD11b-positive cells in shCONTROL and shATF4 cells treated with DOX for 96h. Data represent mean ± SEM of four biological replicates (***p < 0.001; unpaired t-test). F. Annexin V/PI flow cytometry analysis showing the distribution of live, early apoptotic, late apoptotic, and necrotic cells following 96h of DOX treatment. Data represent mean ± SEM of three biological replicates (two-way ANOVA). G. RT-qPCR experiments showing relative mRNA levels of the indicated transcripts in shCONTROL and shATF4 cells treated with DOX for 96 hours. Data were normalized to GAPDH and represent mean ± SEM of three biological replicates (**p < 0.01; unpaired t-test). H. Immunoblot analysis of ATF4, SLC7A5, ASS1, PHGDH and PYCR1 protein levels in shCONTROL and shATF4 cells treated or not with DOX for 96 hours. β-tubulin was used as a loading control.

Journal: bioRxiv

Article Title: BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia

doi: 10.64898/2026.01.19.700325

Figure Lengend Snippet: A. Immunoblot analysis of BCLAF1 and ATF4 protein levels in shCONTROL and shBCLAF1 cells treated with DOX for 96 hours. β-tubulin was used as a loading control. B. Immunoblot analysis of BCLAF1 and ATF4 protein levels in MLL-AF9-expressing AML cells of indicated genotypes. GAPDH was used as a loading control. C. Immunoblot analysis of BCLAF1 and ATF4 protein levels in shCONTROL and shATF4 cells treated with DOX for 96 hours. β-tubulin was used as a loading control. D. Cell proliferation assay (CellTiter-Blue-based) in shCONTROL and shATF4 cells treated or not with DOX for 96 hours, followed by 96 additional hours in culture. Data represent mean ± SEM of three biological replicates (*p < 0.01; paired t-test). E. Flow cytometry analysis showing the percentage of CD11b-positive cells in shCONTROL and shATF4 cells treated with DOX for 96h. Data represent mean ± SEM of four biological replicates (***p < 0.001; unpaired t-test). F. Annexin V/PI flow cytometry analysis showing the distribution of live, early apoptotic, late apoptotic, and necrotic cells following 96h of DOX treatment. Data represent mean ± SEM of three biological replicates (two-way ANOVA). G. RT-qPCR experiments showing relative mRNA levels of the indicated transcripts in shCONTROL and shATF4 cells treated with DOX for 96 hours. Data were normalized to GAPDH and represent mean ± SEM of three biological replicates (**p < 0.01; unpaired t-test). H. Immunoblot analysis of ATF4, SLC7A5, ASS1, PHGDH and PYCR1 protein levels in shCONTROL and shATF4 cells treated or not with DOX for 96 hours. β-tubulin was used as a loading control.

Article Snippet: These samples were stained using CD11b surface marker and Annexin V kit (Annexin V-FITC Kit, Miltenyi Biotec).

Techniques: Western Blot, Control, Expressing, Proliferation Assay, Flow Cytometry, Quantitative RT-PCR

Dynamic changes in angiogenesis induced by OTM. ( A ) Representative CD31 immunofluorescence staining images. CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of CD31 + area in PDL. ( C ) Representative CD31/vascular endothelial growth factor (VEGF) double immunofluorescence staining images. CD31/VEGF staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( D ) Quantitative analysis of VEGF + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; *** p < 0.001; Welch’s ANOVA with Games–Howell post hoc test. PDL: periodontal ligament, AB: alveolar bone.

Journal: Biology

Article Title: Force-Dependent Presence of Senescent Cells Expressing Vascular Endothelial Growth Factor During Orthodontic Tooth Movement

doi: 10.3390/biology15020187

Figure Lengend Snippet: Dynamic changes in angiogenesis induced by OTM. ( A ) Representative CD31 immunofluorescence staining images. CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of CD31 + area in PDL. ( C ) Representative CD31/vascular endothelial growth factor (VEGF) double immunofluorescence staining images. CD31/VEGF staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( D ) Quantitative analysis of VEGF + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; *** p < 0.001; Welch’s ANOVA with Games–Howell post hoc test. PDL: periodontal ligament, AB: alveolar bone.

Article Snippet: CD31 , Endothelial cell marker , Bioss Antibodies (Shanghai, China) , bs-0195R , BF647 , 1:100.

Techniques: Immunofluorescence, Staining, Double Immunofluorescence Staining

Vascular endothelial growth factor (VEGF) expression of senescent cells during OTM. ( A ) Representative p16 and VEGF double immunofluorescence staining images. p16/VEGF staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of p16 + VEGF + area in PDL. ( C ) Schematic illustration of the quantitative analysis for p16 + and VEGF + . ( D ) Quantitative analysis of p16 + VEGF + /VEGF + area in PDL. ( E ) Quantitative analysis of p16 + VEGF + /p16 + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns; not significant, ** p < 0.01; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test for ( B , D ), and Welch’s ANOVA with Games–Howell post hoc test for ( E ). VEGF: vascular endothelial growth factor, PDL: periodontal ligament, AB: alveolar bone.

Journal: Biology

Article Title: Force-Dependent Presence of Senescent Cells Expressing Vascular Endothelial Growth Factor During Orthodontic Tooth Movement

doi: 10.3390/biology15020187

Figure Lengend Snippet: Vascular endothelial growth factor (VEGF) expression of senescent cells during OTM. ( A ) Representative p16 and VEGF double immunofluorescence staining images. p16/VEGF staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of p16 + VEGF + area in PDL. ( C ) Schematic illustration of the quantitative analysis for p16 + and VEGF + . ( D ) Quantitative analysis of p16 + VEGF + /VEGF + area in PDL. ( E ) Quantitative analysis of p16 + VEGF + /p16 + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns; not significant, ** p < 0.01; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test for ( B , D ), and Welch’s ANOVA with Games–Howell post hoc test for ( E ). VEGF: vascular endothelial growth factor, PDL: periodontal ligament, AB: alveolar bone.

Article Snippet: CD31 , Endothelial cell marker , Bioss Antibodies (Shanghai, China) , bs-0195R , BF647 , 1:100.

Techniques: Expressing, Double Immunofluorescence Staining, Staining

Cellular senescence of vascular endothelial cells (ECs) induced by OTM. ( A ) Representative p21 and CD31 immunofluorescence staining images. p21/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of p21 + CD31 + area in PDL. ( C ) Representative p16 and CD31 immunofluorescence staining images. p16/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( D ) Quantitative analysis of p16 + CD31 + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; Kruskal–Wallis with Dunn’s post hoc test. PDL: periodontal ligament, AB: alveolar bone.

Journal: Biology

Article Title: Force-Dependent Presence of Senescent Cells Expressing Vascular Endothelial Growth Factor During Orthodontic Tooth Movement

doi: 10.3390/biology15020187

Figure Lengend Snippet: Cellular senescence of vascular endothelial cells (ECs) induced by OTM. ( A ) Representative p21 and CD31 immunofluorescence staining images. p21/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of p21 + CD31 + area in PDL. ( C ) Representative p16 and CD31 immunofluorescence staining images. p16/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( D ) Quantitative analysis of p16 + CD31 + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; Kruskal–Wallis with Dunn’s post hoc test. PDL: periodontal ligament, AB: alveolar bone.

Article Snippet: CD31 , Endothelial cell marker , Bioss Antibodies (Shanghai, China) , bs-0195R , BF647 , 1:100.

Techniques: Immunofluorescence, Staining

Overlapping analysis of senescent and endothelial markers during OTM. ( A ) Schematic illustration of the overlapping analysis for p21 and CD31 in PDL. ( B ) Quantitative analysis of p21 + CD31 + area/p21 + area. ( C ) Quantitative analysis of p21 + CD31 + area/CD31 + area. ( D ) Schematic illustration of the overlapping analysis for p16 and CD31 in PDL. ( E ) Quantitative analysis of p16 + CD31 + area/p16 + area. ( F ) Quantitative analysis of p16 + CD31 + area/CD31 + area. Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; *** p < 0.001; Welch’s ANOVA with Games–Howell post hoc test for ( B ), one-way ANOVA with Tukey’s test for ( C , F ), and Kruskal–Wallis with Dunn’s post hoc test for ( E ).

Journal: Biology

Article Title: Force-Dependent Presence of Senescent Cells Expressing Vascular Endothelial Growth Factor During Orthodontic Tooth Movement

doi: 10.3390/biology15020187

Figure Lengend Snippet: Overlapping analysis of senescent and endothelial markers during OTM. ( A ) Schematic illustration of the overlapping analysis for p21 and CD31 in PDL. ( B ) Quantitative analysis of p21 + CD31 + area/p21 + area. ( C ) Quantitative analysis of p21 + CD31 + area/CD31 + area. ( D ) Schematic illustration of the overlapping analysis for p16 and CD31 in PDL. ( E ) Quantitative analysis of p16 + CD31 + area/p16 + area. ( F ) Quantitative analysis of p16 + CD31 + area/CD31 + area. Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; *** p < 0.001; Welch’s ANOVA with Games–Howell post hoc test for ( B ), one-way ANOVA with Tukey’s test for ( C , F ), and Kruskal–Wallis with Dunn’s post hoc test for ( E ).

Article Snippet: CD31 , Endothelial cell marker , Bioss Antibodies (Shanghai, China) , bs-0195R , BF647 , 1:100.

Techniques:

VEGF-expressing senescent ECs. ( A ) Representative p16, CD31, and VEGF triple immunofluorescence staining images. p16/CD31/VEGF staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of p16 + CD31 + VEGF + area in PDL. ( C ) Schematic illustration of the quantitative analysis for p16, CD31, and VEGF in PDL. ( D ) Quantitative analysis of p16 + CD31 + VEGF + area/p16 + CD31 + area. ( E ) Quantitative analysis of p16 + CD31 + VEGF + area/p16 + VEGF + area. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, ** p < 0.01; **** p < 0.0001; Kruskal–Wallis with Dunn’s post hoc test for ( B ), and one-way ANOVA with Tukey’s test for ( D , E ). VEGF: vascular endothelial growth factor, PDL: periodontal ligament, AB: alveolar bone.

Journal: Biology

Article Title: Force-Dependent Presence of Senescent Cells Expressing Vascular Endothelial Growth Factor During Orthodontic Tooth Movement

doi: 10.3390/biology15020187

Figure Lengend Snippet: VEGF-expressing senescent ECs. ( A ) Representative p16, CD31, and VEGF triple immunofluorescence staining images. p16/CD31/VEGF staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of p16 + CD31 + VEGF + area in PDL. ( C ) Schematic illustration of the quantitative analysis for p16, CD31, and VEGF in PDL. ( D ) Quantitative analysis of p16 + CD31 + VEGF + area/p16 + CD31 + area. ( E ) Quantitative analysis of p16 + CD31 + VEGF + area/p16 + VEGF + area. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, ** p < 0.01; **** p < 0.0001; Kruskal–Wallis with Dunn’s post hoc test for ( B ), and one-way ANOVA with Tukey’s test for ( D , E ). VEGF: vascular endothelial growth factor, PDL: periodontal ligament, AB: alveolar bone.

Article Snippet: CD31 , Endothelial cell marker , Bioss Antibodies (Shanghai, China) , bs-0195R , BF647 , 1:100.

Techniques: Expressing, Immunofluorescence, Staining

Presence and distribution of senescent cells during OTM. ( A ) Representative p21 and p16 immunofluorescence staining images with DAPI. ( B ) Quantitative analysis of p21 + area in PDL. ( C ) Quantitative analysis of p16 + area in PDL. ( D , E ) Distribution of senescence marker–positive areas in the 60 g and 180 g groups. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). * p < 0.05; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test. PDL: periodontal ligament, AB: alveolar bone.

Journal: Biology

Article Title: Force-Dependent Presence of Senescent Cells Expressing Vascular Endothelial Growth Factor During Orthodontic Tooth Movement

doi: 10.3390/biology15020187

Figure Lengend Snippet: Presence and distribution of senescent cells during OTM. ( A ) Representative p21 and p16 immunofluorescence staining images with DAPI. ( B ) Quantitative analysis of p21 + area in PDL. ( C ) Quantitative analysis of p16 + area in PDL. ( D , E ) Distribution of senescence marker–positive areas in the 60 g and 180 g groups. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). * p < 0.05; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test. PDL: periodontal ligament, AB: alveolar bone.

Article Snippet: p21 , Senescence marker , Bioss Antibodies (Shanghai, China) , bs-10129R , AF555 , 1:100.

Techniques: Immunofluorescence, Staining, Marker

Cellular senescence of vascular endothelial cells (ECs) induced by OTM. ( A ) Representative p21 and CD31 immunofluorescence staining images. p21/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of p21 + CD31 + area in PDL. ( C ) Representative p16 and CD31 immunofluorescence staining images. p16/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( D ) Quantitative analysis of p16 + CD31 + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; Kruskal–Wallis with Dunn’s post hoc test. PDL: periodontal ligament, AB: alveolar bone.

Journal: Biology

Article Title: Force-Dependent Presence of Senescent Cells Expressing Vascular Endothelial Growth Factor During Orthodontic Tooth Movement

doi: 10.3390/biology15020187

Figure Lengend Snippet: Cellular senescence of vascular endothelial cells (ECs) induced by OTM. ( A ) Representative p21 and CD31 immunofluorescence staining images. p21/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of p21 + CD31 + area in PDL. ( C ) Representative p16 and CD31 immunofluorescence staining images. p16/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( D ) Quantitative analysis of p16 + CD31 + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; Kruskal–Wallis with Dunn’s post hoc test. PDL: periodontal ligament, AB: alveolar bone.

Article Snippet: p21 , Senescence marker , Bioss Antibodies (Shanghai, China) , bs-10129R , AF555 , 1:100.

Techniques: Immunofluorescence, Staining